We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A federal jury in Houston, Texas found a drug compounder guilty of billing the federal government more than $20 million for unnecessary compounds. Read More
President Trump sent a list of “principles” to lawmakers this week, outlining what the administration wants to see in a drug pricing bill as a Senate bill with some of the president’s ideas moves toward passage this spring. Read More
The Centers for Medicare and Medicaid Services (CMS) unveiled a model program that will cap Medicare Part D out-of-pocket insulin costs for seniors at $35 per month, and all three manufacturers for the U.S. market — Eli Lilly, Sanofi and Novo Nordisk — said they will take part. Read More
Leaders of the House Energy and Commerce Committee asked FDA Commissioner Stephen Hahn how the agency intends to weigh priorities for the notification of shortages while protecting commercial information as the coronavirus continues to spread. Read More